Natco Pharma Limited announced that the Board of Directors of the company at its meeting held on November 12, 2014, Mr. P S R K Prasad, Executive Vice President (Corporate Engineering Services) appointed as Additional Director of the company who will be in the whole time employment of the company. Mr. S V V N Appa Rao, Vice President (Finance & Accounts) appointed as Interim (Chief Financial Officer) of the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,010 INR | +0.99% | -3.13% | +23.25% |
05-28 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
05-28 | Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.25% | 2.16B | |
+42.60% | 748B | |
+32.34% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.47% | 245B | |
+9.26% | 211B | |
-5.07% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Natco Pharma Limited Announces Management Appointments